In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism Jeffrey L. Evelhoch OriginalPaper Pages: 5 - 12
Cellular pharmcology of fluorinated pyrimidines in vivo in man John S. KovachRobert W. Beart Jr. OriginalPaper Pages: 13 - 25
Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration Colin Paul SpearsBengt G. GustavssonRoland Frösing OriginalPaper Pages: 27 - 36
5-Fluorouracil containing combinations in murine tumor systems Thomas H. CorbettMarie-Christine BisseryLisa Polin OriginalPaper Pages: 37 - 49
Design of some nucleic acid antimetabolites: Expectations and reality Jerome P. Horwitz OriginalPaper Pages: 51 - 57
Biochemical mechanisms in colon xenografts: Thymidylate synthase as a target for therapy Peter J. HoughtonJanet A. HoughtonSaeed Radparvar OriginalPaper Pages: 59 - 69
Clinical trials with fluorinated pyrimidines in patients with head and neck cancer Muhyi Al-Sarraf OriginalPaper Pages: 71 - 81
Dynamic management of squamous cell cancer of the anal canal Norman D. NigroV. K. VaitkeviciusBasil Considine Jr. OriginalPaper Pages: 83 - 89
Cancer of the Esophagus: The Wayne State University experience Lawrence Leichman OriginalPaper Pages: 91 - 100
The clinical syndrome of 5-fluorouracil cardiotoxicity John F. EnsleyBharat PatelMuhyi Al-Sarraf OriginalPaper Pages: 101 - 109